Clinical Trials Logo

Clinical Trial Summary

Patients with type 1 diabetes (T1DM) who are unable to perceive symptoms of hypoglycemia, referred to as impaired awareness of hypoglycemia (IAH), are at very high risk of severe hypoglycemia. IAH affects approximately 25% of patients with T1DM. Brain lactate may be involved in the development of IAH. A recent study indicated increased brain lactate utilization during hypoglycemia in T1DM patients with IAH, which did not occur in patients with normal awareness of hypoglycemia (NAH). Conversely, administration of lactate to patients with NAH has been shown to attenuate counterregulatory hormone responses to and symptomatic awareness of hypoglycemia, thus causing a situation that resembles IAH. It has, however, not been demonstrated whether the excess of lactate is actually taken up or metabolized by the brain, and if so whether this occurs under euglycemic or hypoglycemic conditions or both.

This project consists of two related studies. The objective of part 1 is to investigate the effect of elevated plasma lactate levels that are sufficient to impair awareness of hypoglycemia on brain lactate concentrations during euglycemia and hypoglycemia in T1DM patients with NAH. The objective of part 2 is to compare the effect of exogenous lactate on brain lactate concentrations between T1DM patients with NAH and T1DM patients with IAH.

Furthermore, this study aims to determine the effect of acute hypoglycemia on the inflammatory function and composition of peripheral blood mononuclear cells.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03286816
Study type Interventional
Source Radboud University
Contact
Status Completed
Phase N/A
Start date November 2016
Completion date August 2017

See also
  Status Clinical Trial Phase
Completed NCT04712266 - A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes Early Phase 1
Recruiting NCT05967260 - DailyDose Smart Snack Study for T1D on MDI N/A
Completed NCT06097689 - A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus N/A
Recruiting NCT05221359 - Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes N/A
Recruiting NCT06382350 - Glycemic Excursions in Patients With Type 1 Diabetes Mellitus Using Closed-loop Systems
Recruiting NCT04266379 - Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia N/A
Completed NCT03163511 - A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness Phase 1/Phase 2
Recruiting NCT05762107 - A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes Phase 2
Active, not recruiting NCT04614168 - Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes N/A
Completed NCT03028220 - Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous Glucose Data N/A
Enrolling by invitation NCT04233138 - SUPPORT Online Training Platform for Type 1 Diabetes Self-management Education and Support (SUPPORT) N/A
Recruiting NCT04664764 - Intermediate and Long Acting Insulin Young Children Type 1 Diabetes. Phase 4